Central Serous Chorioretinopathy (CSC) Completed Phase 1 Trials for Ranibizumab (DB01270)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00403325Intravitreal Ranibizumab Treatment of Central Serous ChorioretinopathyTreatment